By Product
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2014/FY
2013/FY
2012/FY
2011/FY
Stock NameRevenueRatio
小分子CDMO解决方案4.73B70.98%
新兴业务1.93B28.92%
Other business6.4M0.10%
By Industry
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2014/FY
2013/FY
2012/FY
2011/FY
Stock NameRevenueRatio
Pharmaceutical industry6.66B99.90%
Other business6.4M0.10%
By Country/Region
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2014/FY
2013/FY
2012/FY
2011/FY
Stock NameRevenueRatio
境外(包括北美、欧洲、除中国大陆地区以外的亚洲地区)4.92B73.77%
境内(中国大陆地区)1.75B26.23%
